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Abstract
Background: RNA interference (RNAi) is a specific and effective approach for inhibiting viral replication by
introducing double-stranded (ds)RNA targeting the viral gene. In this study, we employed a combinatorial
approach to interfere multiple gene functions of white spot syndrome virus (WSSV), the most lethal shrimp
virus, using a single-batch of dsRNA, so-called “multi-WSSV dsRNA.” A co-cultivation of RNase-deficient E. coli
was developed to produce dsRNA targeting a major structural protein (VP28) and a hub protein (WSSV051)
with high number of interacting protein partners.
Results: For a co-cultivation of transformed E. coli, use of Terrific broth (TB) medium was shown to improve
the growth of the E. coli and multi-WSSV dsRNA yields as compared to the use of Luria Bertani (LB) broth. Co-culture
expression was conducted under glycerol feeding fed-batch fermentation. Estimated yield of multi-WSSV dsRNA
(μg/mL culture) from the fed-batch process was 30 times higher than that obtained under a lab-scale culture with LB
broth. Oral delivery of the resulting multi-WSSV dsRNA reduced % cumulative mortality and delayed average time to
death compared to the non-treated group after WSSV challenge.
Conclusion: The present study suggests a co-cultivation technique for production of antiviral dsRNA with
multiple viral targets. The optimal multi-WSSV dsRNA production was achieved by the use of glycerol feeding
fed-batch cultivation with controlled pH and dissolved oxygen. The cultivation technique developed herein
should be feasible for industrial-scale RNAi applications in shrimp aquaculture. Interference of multiple viral
protein functions by a single-batch dsRNA should also be an ideal approach for RNAi-mediated fighting
against viruses, especially the large and complicated WSSV.
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Background
White spot syndrome virus (WSSV), a major pathogen
with high infectivity and mortality, has been a serious
threat for penaeid shrimp aquaculture in the past two
decades. WSSV is a large double-stranded DNA virus
with the approximate genome size of 300 kbp [1–3].
Most of their putative translated gene products have no
homology to other proteins from viruses or host cells.
The uniqueness of WSSV therefore classified the
virus into its own family Nimaviridae and genus
Whispovirus [4]. Several aspects including morphology
and pathogenicity of WSSV have been intensively
studied to seek prevention and therapeutic treatment.
The viral control strategies were included administra-
tion of recombinant WSSV proteins and DNA vaccine
based constructs [1, 5–8]. Application of immunosti-
mulants were also introduced to shrimp to fight
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against WSSV infection [9, 10]. Nevertheless, no prac-
tical and effective methods have been established to
control WSSV yet.
Application of RNA interference (RNAi) or double-
stranded (ds)RNA-mediated viral inhibition has been
shown to be a promising anti-WSSV strategy [11–15]. In
this study, we proposed a combinatorial approach to
interfere multiple WSSV gene expression using a single
batch of dsRNA (hereafter called “multi-WSSV dsRNA”).
Targeting multiple viral targets by dsRNA could possibly
result in additive inhibition; however, more importantly,
this approach should lower the chance of viral escape
that needs to have multiple resistance mutations within
the dsRNA targets occurred simultaneously [16]. The
target viral genes in this study include a major structural
protein (VP28) and a hub protein (WSSV051). VP28 is
involved in the viral entry to shrimp cells, and injection
of dsRNA corresponding to VP28 was shown to effect-
ively protect shrimp against the virus [11, 13, 14]. Oral
administration of VP28-specific dsRNA was demonstrated
as a potential therapeutic method by improving shrimp
survival rate after WSSV challenge [17]. WSSV051, also
known as structural protein VP55, has been recently
identified as one of the hub proteins from the WSSV
protein-protein interaction network [15]. The hub
function is to hold the proteins together in the net-
work therefore knock-down of WSSV hubs would be
expected to collapse WSSV functions, and silencing
this gene by specific dsRNA could delay shrimp mor-
tality after WSSV infection [15].
Here, a co-cultivation of RNase-deficient E. coli was
developed to produce multi-WSSV dsRNA, and large-
scale production of the multi-WSSV dsRNA was opti-
mized through a glycerol feeding fed-batch fermentation.
Feed pellets formulated with the multi-WSSV dsRNA
were prepared according to the method described by
Saksmerprome et al. [18], and their antiviral efficacy was
also examined.
Methods
Co-cultivation of two strains of RNase-deficient E. coli to
produce dsRNA targeting multiple WSSV genes
Construction of hairpin expression vector targeting
VP28 (GenBank no. AY422228.1, nucleotides 8–189)
was developed according to the method described by
Saksmerprome et al. [19]. The plasmid encoding WSSV-
VP28 of 181-bp was used as a template for PCR. Primers
used for amplification of DNA template for dsRNA-
VP28 synthesis are VP28F (5′ TTT CTT TCA CTC
TTT CGG TCG T 3′) and VP28R1 (5′ GCC TGA TCC
AAC CTC AGC AGT C 3′). The conditions for PCR
amplification were as follows: 3 min at 94 °C, 35 cycles
of 30 s at 94 °C, 30 s at 53 °C and 30 s at 72 °C and
extension at 72 °C for 5 min. The other construct
targeting WSSV051 (GenBank no. AF440570, nucleo-
tides 28034–28316) was performed with modified proto-
cols from Sangsuriya et al. [15]. An amplified amplicon
of 393 bp was obtained from a PCR reaction using spe-
cific primers: 051siF (5′ TTC AGG GCG GCT ATC
TTA TG) and 051siR2 (5′ TCA TCT TCT TCC ATG
ACA TC3′) and DNA extracted from WSSV-infected gill
tissues as template. The conditions for PCR amplifica-
tion were as follows: 3 min at 94 °C, 35 cycles of 30 s at
94 °C, 30 s at 55 °C and 30 s at 72 °C and extension at
72 °C for 5 min. The PCR product was then purified and
cloned in a sense orientation downstream of the T7 pro-
moter of pDrive vector (QIAGEN). Subsequently, an
amplicon of 283 bp obtained using a primer set harbor-
ing XbaI and HindIII restriction sites (XbaI-051siF: 5′
GC TCTAGA TTC AGG GCG GCT ATC TTA 3′ and
HindIII-051siR3: 5′ AC AAGCTT AAA GAA AAC
CCC TTC TGG 3′) was cloned in an antisense orienta-
tion downstream of the first fragment. The hairpin con-
structs containing both sense and antisense strands were
then verify by DNA sequencing.
Each recombinant plasmid was transformed into RNase
III-deficient E. coli HT115 (DE3) for long dsRNA produc-
tion. Two types of cultivation medium, Luria Bertani (LB)
and Terrific broth (TB), were used to achieve the optimal
production of bacteria cells and dsRNA. LB medium con-
sisted 1 % (w/v) tryptone, 0.5 % (w/v) yeast extract, and
1 % (w/v) NaCl. Composition of TB medium was 1.2 %
(w/v) tryptone, 2.4 % (w/v) yeast extract, 0.72 M potas-
sium phosphate (dibasic), 0.17 M potassium phosphate
(monobasic), and 0.4 % (v/v) glycerol. For a starter culture,
a single transformant colony for each dsRNA population
was inoculated into 3 mL of either LB or TB medium in
the presence of 100 μg/mL ampicillin and 12 μg/mL tetra-
cycline. The culture was shaken at 250 rpm, 37 °C until
OD600 nm of 3.5–4.0 was obtained (approximately 16 h).
Co-inoculation was subsequently performed at the ratio
1:100 (v/v) in fresh medium. The co-culture was shaken
for 8 h at 37 °C, and was collected for analysis.
Fermentation processes for large-scale production of
multi-WSSV dsRNA
Large-scale production of multi-WSSV dsRNA was con-
ducted in a 10-L bioreactor at Biochemical Engineering
and Pilot Plant Research and Development Unit (BEC)
of KMUTT, Thailand. The starter culture was prepared
as described above. Co-inoculation was performed at the
ratio 1:40 (v/v) in 5-L fresh medium containing 100 μg/
mL ampicillin and 12 μg/mL tetracycline. For both batch
and fed-batch fermentation, temperature was maintained
at 37 °C and pH was kept at 7.0 using 1 M NH4OH.
Dissolved oxygen (DO) was controlled at 30 % of air sat-
uration. Batch fermentation was run for 8 h, and 50 ml
of the culture were collected for analysis. The remaining
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culture underwent the fed-batch process by feeding
500 g/L of glycerol as the carbon source at the rate of
2.9 mL/h. Fed-batch fermentation was continued until
sequential increasing of DO (%) value was indicated as
the decline phase (or cultivation time of 30 h), and
50 mL of fed-batch culture were collected for analysis.
Cell concentrations (CFU/mL) obtained from lab-scale
and large-scale fermentation were determined by meas-
uring UV absorbance at 600 nm, and 1 OD600nm is
equivalent to 109 CFU/mL. RNA extraction was per-
formed using phenol-chloroform method [20]. Reverse
transcription (RT)-PCR and 1.5 % agarose gel electro-
phoresis were performed to indicate the presence of
WSSV-specific dsRNA. The primer pairs for detection of
WSSV05-dsRNA are XbaI-051siF and HindIII-051siR3,
for detection of VP28-dsRNA are VP28F and VP28R1.
The RT-PCR conditions to detect WSSV051-dsRNA
were as follows: 5 min at 50 °C, 5 min at 94 °C, 35 cycles
of 10 s at 94 °C, 30 s at 55 °C and 30 s at 68 °C and
extension at 68 °C for 5 min, whereas VP28-dsRNA
detection were as follows: 5 min at 50 °C, 5 min at
94 °C, 35 cycles of 10 s at 94 °C, 30 s at 53 °C and
30 s at 68 °C and extension at 68 °C for 5 min. Nuclease
digestion experiments using RNase A and RNase III were
performed as described in Saksmerprome et al. [19] to
examine quality and integrity of each dsRNA production.
The amount of dsRNA was quantitated by measuring UV
absorbance at 260 nm, and dsRNA concentration
extracted from 1 mL culture was calculated in μg/μl.
Feed preparation
Four formulas of feed, with different types and doses of
dsRNA, were tested; 1) 6 mg of WSSV051-dsRNA, 2)
6 mg of VP28-dsRNA, 3) 6 mg of multi-WSSV dsRNA
and 4) 12 mg of multi-WSSV dsRNA. For detailed feed
preparation, the commercial shrimp feed (OMEG 1704 S,
BETAGRO) was ground using a blender. One kilogram of
mashed feed was mixed with 500-mL of the co-culture
thoroughly. Feed mixture was pelleted by pressing
through 10-mL syringe (2 mm in diameter), and the feed
pellets were dried at 60 °C in hot air oven for 24 h. To in-
dicate the presence dsRNA in feed, extracted RNA from
0.1 g feed pellets were subjected to RT-PCR using
WSSV051- and VP28-specific primers. The same proced-
ure was repeated on the formulated feed kept at 20–25 °C
for 7 months to examine dsRNA stability in feed.
Oral administration of multi-target dsRNA and WSSV
challenge
Penaeus vannamei shrimp with the average size of 3–
5 g were acclimatized for 3 days in 15 ppt of artificial
seawater with aeration, and were arbitrarily divided into
6 groups (n = 10) with 3 replicates of each group. Four
groups received the dsRNA-formulated feed, while the
WSSV-positive and negative controls received commercial
feed without modification. Feeding dose rate was at 4 % of
their body weight, and shrimp were fed twice a day. Indi-
vidual 5-g shrimp in groups that received single- and
double-dose formulas would receive 1.2 and 2.4 μg dsRNA
per meal at the most, respectively. After 5-day feeding, all
animals, except the WSSV-negative control group, were
injected with 105 copies of WSSV (LD50 = 4 days) per
shrimp. The animals were fed continuously with the
assigned feed for the next 7 days. Shrimp mortality of each
group was recorded, and the average time to death was cal-
culated accordingly. Data on average time to death was an-
alyzed by t-test analysis using SPSS18.0 software, P < 0.05.
Results and Discussion
A single co-cultivation with Terrific Broth medium
resulted in high cell density and dsRNA yield
The effect of culture medium on productivity of E. coli ex-
pression system has been studied by varying various media
to achieve the optimal production of bioactive compounds
[21, 22], indicating the need for optimization of culture
conditions when attempting cultivation of new species.
Previous work by our group demonstrated the production
of dsRNA against shrimp viruses in RNase-deficient E. coli
using LB broth medium [18, 19, 23, 24]. A single popula-
tion of dsRNA against an individual shrimp viral gene is
produced in the range of a few micrograms per 100 mL E.
coli culture under a lab-scale experiment. In this study, we
tested to see if use of Terrific broth (TB), a culture medium
that is commonly used in culture conditions for protein
overexpression [22, 25, 26] would enhance the productivity
of co-cultivated bacteria as compared to the original condi-
tion with LB broth. For a small-scale cultivation, final cell
density (CFU/mL) and dsRNA production (μg/mL culture)
in the culture with TB medium were both approximately
2x those of the culture with LB broth (Table 1). The en-
hanced cell growth and dsRNA yield under TB condition
could be explained as follows. TB is a nutritionally rich
medium containing a 4.8-time higher yeast extract relative
to LB broth. Yeast extract is a main component for the
growth of microorganism. It contains nitrogenous com-
pounds, carbon, sulfur, trace nutrients, vitamin B complex
and other important growth factors. The additional 0.4 %
glycerol is also provided in TB broth as an extra carbon
source. Moreover, TB medium contains K2HPO4 and
KH2PO4 which function as buffer medium, therefore the
pH of the TB medium is maintained to optimize culture
condition during the cell growth [21, 22, 25, 27].
Fed-batch glycerol feeding strategy for large-scale
production of multi-WSSV dsRNA
Two fermentation processes in 10-L bioreactor were
employed using TB medium for large-scale production of
Thammasorn et al. BMC Biotechnology  (2015) 15:110 Page 3 of 7
multi-WSSV dsRNA. For a conventional batch fer-
mentation, the final cell density (CFU/mL) at 8-h
cultivation time significantly increased, although dsRNA
yield (μg/mL) was half of that obtained in the lab-scale
cultivation with TB broth (Table 1). Without additional
supplements under the continuous fermentation process,
lack of nutrients in high-density culture could limit
dsRNA production. In addition, formation of inhibitory
factors, such as acetate by-product of aerobic fermenta-
tion in the presence of high concentration of carbon
source, could have negative effects on growth and E. coli
and productivity of its products [28–30]. Slow glycerol
feeding fed-batch fermentation with controlled dissolved
oxygen and pH stability is recommended to improve high
cell density and product yields by maintaining the optimal
specific growth rate during process [28, 29]. The propaga-
tion technique is widely used for production of various
bioactive products, including DNA plasmids for vaccine
and recombinant proteins [25, 31, 32]. As shown in
Table 1, cell density of 36.2× 109 ± 4.5× 109 CFU/mL was
obtained at 30-h fed-batch process, producing approxi-
mately 95.0 ± 21.5 μg of multi-WSSV dsRNA. The amount
of dsRNA as determined from the 1-mL fed-batch culture
was almost 30 times higher than the yield obtained under
the batch fermentation. RT-PCR followed by 1.5 % agarose
gel electrophoresis indicated the presence of dsRNA tar-
geting VP28 (181 bp) and dsRNA targeting WSSV051
(283 bp) in all experiments (Fig. 1a). Evidence for double-
stranded nature of the synthesized dsRNAs was obtained
from nuclease digestion experiments using RNase A and
RNase III depicted in Fig. 1a. Both VP28- and WSSV051-
dsRNA were proved to be genuine since they were
digested by RNase III but not by RNase A (Fig. 1b).
Oral administration of feed formulated with multi-WSSV
dsRNA reduced shrimp mortality and delayed time to
death after WSSV challenge
To test the protective efficacy against the virus of multi-
WSSV dsRNA relative to a single gene-targeted dsRNA,
feed were formulated to contain single (VP28 or
WSSV051) and multiple types (multi-WSSV) with the
same quantity of total dsRNA (6 mg each per 1-kg feed).
The multi-WSSV formulated feed kept at room
temperature for 7 months was examined by RT-PCR,
and was found to still maintain both VP28- and
WSSV051-dsRNA (Fig. 2). All types of the formulated
feed were given to shrimp for 5 days prior to WSSV
challenge. The dsRNA-treated groups were monitored in
parallel to the control animals for their mortality rate
(Fig. 3a) and average time to death, i.e. time when the
highest accumulated mortality observed (Fig. 3b). As
expected, the WSSV-positive control group showed
mortality at 1 day post infection (dpi), and cumulative
mortality reached 100 % by the 7th dpi, whereas no
cumulative morality observed in the negative-WSSV
group at the end of experiment. Comparative efficacy of
VP28- and WSSV051- and multi-WSSV dsRNA was also
investigated at the same dsRNA quantity per kg feed.
WSSV051-dsRNA group showed cumulative mortality of
60 % at 7 dpi, and average time to death of 6 d., afford-
ing the least protection among the three groups exam-
ined in this study. Viral protective effect of multi-WSSV
dsRNA appeared to be intermediate between those of
VP28- and WSSV051-dsRNA. The variation of antiviral
efficacy might be due to the different targeted genes and
their functions in host cells. VP28 is functionally in-
volved in entry step into shrimp cells therefore suppres-
sion of this gene resulted in inhibition of viral infection.
Although WSSV051 was identified as hub protein, its
actual function in shrimp is not yet revealed. To increase
efficiency of viral inhibition by WSSV051 dsRNA alone,
its higher quantity might be required.
Several WSSV genotypes have been extensively re-
vealed, and this genetic variation is essential to describe
viral epidemiology and evolutionary (see review by
Shekar M et al. [33]). For instance, the complete genomes
of three strains of WSSV-TH (AF369029), WSSV-CN
(AF332093) and WSSV-TW (AF440570) were reported,
indicating the genetic variations including (i) a large dele-
tion of 13.2 kb in the WSSV-TH; (ii) a genetically variable
region found in the WSSV-TH; (iii) an insert of transpos-
able elements in the WSSV-TW; (iv) variation in the num-
ber of repeat units within homologous regions and direct
repeats; (v) insertions or deletions of single nucleotide
mutations and single nucleotide polymorphisms [34]. The
differences in genetic content have also been accounted
for viral virulence [35–37]. Moreover, mixed-genotypes of
WSSV have been investigated in both experimental and
natural infections [35, 36, 38]. Therefore, to combat
WSSV infection that might cause by different strains and
Table 1 Determination of cell concentrations and dsRNA yields obtained from a single co-cultivation of RNase-deficient E. coli
Production scale Type of process Medium Cell density (×109 CFU/mLa) dsRNAyield (μg/mLa) Incubation time (hr.)
Laboratory - LB 2.4 ± 0.2 2.6 ± 0.8 8
- TB 4.5 ± 0.1 6.2 ± 0.2 8
Large Batch TB 21.1 ± 2.9 3.4 ± 0.5 8
Fed-batch TB 36.2 ± 4.5 95.0 ± 21.5 30
a1 mL of bacteria culture
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virulence, multiple targets would be a better approach to
control viral escape.
Dose dependent effect of dsRNA was also assessed by
doubling dose of multi-WSSV in the last formula (12 mg
per 1-kg feed). Throughout the experimental time, %
mortality of the groups received multi-WSSV dsRNA, at
either single or double dose, was significantly lower than
that of the WSSV-positive group that did not receive
any dsRNA. Average time to death of both single- and
double-dose multi-WSSV dsRNA groups were delayed
to 7–8 days, while that of the viral positive control was
approximately 5 days. Increasing dose of multi-WSSV,
from 6 to 12 mg/kg feed, slightly reduced % mortality. It
would be interesting to see if significant dose-dependent
Fig. 2 Detection of multi-WSSV dsRNA in the freshly-formulated feed and the formulated-feed stored at 20–25 °C for 7 months. Lanes VP28,
VP28-dsRNA; 051, WSSV051-dsRNA; +, positive control using plasmid expressing hairpin VP28 and WSSV051 as templates; −, negative control
using DEP-C water as template; M, 2-log DNA ladder
Fig. 1 a Identification of multi-WSSV dsRNA in a single-batch culture by RT-PCR. Lanes M, 2log marker; lanes 1–2, laboratory-scale production with
LB and TB medium, respectively; lanes 3–4, large-scale production under batch and fed-batch processes, respectively; Lane -, negative control
using DEP-C water as template. b Integrity analysis of individual single-targeted dsRNA from bacterial cells. E. coli HT115 expressed WSSV051 and
VP28 dsRNA were subjected for dsRNA extraction. The respective dsRNAs were characterized by nuclease treatments using RNase A and RNase III
for digestion of the ssRNA and dsRNA, respectively
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effect of multi-WSSV dsRNA would be observed under
a farm-scale experiment as previously reported by Saks-
meprome et al. [18].
Conclusions
This report described the methodology on using co-
cultivation approach for large-scale production of dsRNA
targeting multiple WSSV genes. First, a single co-
cultivation with Terrific Broth medium, where RNase-
deficient bacteria expressing different types of dsRNA are
simultaneously inoculated, is efficient and time-saving for
production of multi-target dsRNA. For large-scale produc-
tion, fed-batch fermentation with glycerol feeding should
be suitable for industrial use of RNAi in shrimp aquacul-
ture. The amount of dsRNA as determined from fed-
batch culture was almost 30 times higher than the yield
obtained under the conventional batch fermentation.
Interim analysis showed that oral application of multi-
WSSV dsRNA significantly reduced % shrimp mortality
and delayed time to death relative to the WSSV positive
control. Despite the intermediate effect of the multi-
WSSV dsRNA, compared to the single-targeted dsRNA
(VP28 and WSSV051), the use of multiple-target dsRNA
should still be encouraged for better controlling the com-
plex WSSV with large genetic variations. Sequence ana-
lysis of individual dsRNA components may be necessary
to minimize intermolecular interference among them
when designing multiple-targeted dsRNA for optimal
silencing effect.
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